Metrics as of 10/17/2026, 08:43 AM (Berlin time), refresh in progress.
Accendra Health Stock
Accendra Health, Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Distribution
- Country
- United States
- CEO
- Kenneth Gardner-Smith
- Employees
- 6,500
- Market cap
- $18 M
- IPO
- 17/03/1980
Accendra Health, Inc., along with its subsidiaries, operates globally as a comprehensive provider of healthcare solutions. The organization is structured into two primary operational divisions: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment offers a wide array of goods…
Accendra Health stock: price history
1D
-10.1%
1W
-45.1%
1M
-78.0%
6M
-93.0%
YTD
-91.6%
1Y
-94.9%
2Y
-98.3%
5Y
-99.3%
10Y
-99.3%
Next earnings date
Next earnings date
29/10/2026 (in 12 days)
Volatility around earnings
~197% stronger price swings than usual
Ask the agents about Accendra Health
Analyst assessment of Accendra Health
PRICE TARGET LOW
US$1.50
CONSENSUS
US$1.50
MEDIAN
US$1.50
PRICE TARGET HIGH
US$1.50
0
STRONG BUY
2
BUY
11
HOLD
2
SELL
0
STRONG SELL
15
TOTAL · Hold
As of: 13/08/2026
Accendra Health stock metrics
P/E
-0.06
P/B
-0.03
EV/EBITDA
7.8
RETURN ON EQUITY
16.2%
NET MARGIN
-14.5%
DEBT/EQUITY
-3.23
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
73.0%
FLOAT SHARES
56,165,812
AVG. DAILY VOLUME (30D)
1,598,694
Insider transactions (SEC)
Gardner-Smith Kenneth
Leon Jonathan A
Galloway Heath H
Pesicka Edward A
Leon Jonathan A
Institutional holders
Dividends & Stock splits
Dividends
Stock splits
Comparable stocks
Frequently asked questions about Accendra Health stock
What does Accendra Health do?
Accendra Health, Inc. is a company in the Healthcare sector, Medical - Distribution industry, headquartered in United States.
The CEO is Kenneth Gardner-Smith, the company employs around 6,500 people.
The IPO was on 17/03/1980; the stock trades on NYSE under the ticker ACH.
What do analysts say about Accendra Health stock?
15 analysts rate the stock, the consensus is Hold (as of 13/08/2026).
The average price target is US$1.50, ranging from US$1.50 to US$1.50, with a median of US$1.50.
This is an external assessment, not a statement by Market Jury.
When does Accendra Health report next?
The next earnings date is 29/10/2026.
Around past earnings, price swings were roughly 197% stronger than usual.
Does Accendra Health pay a dividend?
Yes. The last dividend was US$0.00 per share, ex-date 14/12/2021, paid on 31/12/2021.
The dividend yield is 0.0% (as of 30/06/2026).
Which stocks are comparable to Accendra Health?
Comparable stocks include McKesson, Cencora, Cardinal Health, Henry Schein, DocMorris, Eli Lilly and Company, Johnson & Johnson and AbbVie.
How can I get Accendra Health stock analyzed?
Clicking "Analyze stock" lets five strategies assess Accendra Health against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.